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The special problems associated with enzyme method control are:
(1) Enzyme specimens are poorly stable, and this may impair evaluation of between-day method precision.
(2) Clinical enzyme methods measure catalytic activity, not concentration. A 'true' analyte value cannot be stated since observed activities are method-dependent. Accuracy, in the strict sense is, therefore, unobtainable, and consensus values obtained by standardised methodology must be substituted.
(3) In many enzyme methods, a second enzyme is added to measure the product of the original enzyme. These indicator enzymes may themselves be unstable and require determination of their activity.
(4) There are no primary standards for enzyme methods. Though attempts have been made to utilise weighed amounts of purified enzymes as standards, their dilution and attempts at stabilisation may alter their properties and they may not react in a manner similar to patient specimens.
(5) Control materials used either as controls or as secondary standards show similar limitations, particularly if they are not of human origin, and their quoted or assigned values are method-dependent.
(6) Even routine clinical specimens will not all act identically with a particular method, since enzyme properties may vary with the tissue source, sample iso-enzyme composition, and sample dilution.
(7) Method interference from inhibitors in specimens or reagents also provides a frequently encountered problem in enzyme methodology. Though pre-analytic control of patient status, sampling and sample handling, and post-analytic treatment of data deserve mention, I wish to concentrate particularly on analytic control. This includes control of methodology, instrumentation, reagents, calibration and control materials, and the use of patient samples (duplicate and repeat analysis and the so-called average of normals).
METHODOLOGY
As long as enzymes are determined by their catalytic activity, the result will be method-dependent and will vary with the substrate chosen for analysis and its concentration, the reaction pH, the buffer and its molarity, reagent purity, and, of course, the determination temperature. Observed values will also differ, depending upon the reaction direction chosen, for example, the forward or reverse lactate dehydrogenase procedures.
With so many variables we might expect poor intralaboratory precision. In fact, the mean betweenbatch intralaboratory precision for a series of American University Hospitals recently studied by Kurtz and co-workers (1977) showed a coefficient of variation of less than 7 % at the upper limit of normal for aspartate transaminase, alkaline phosphatase, and lactate dehydrogenase. Creatine kinase showed nearly double this variation. A common criterion of acceptable performance is that analytical variation should constitute less than one-half of biological variation (Cotlove et al., 1970) . With this criterion, this analytical performance would be acceptable; however, these precision results fall far short of what most clinical laboratories can achieve in comparable non-enzyme procedures.
INSTR UMENTATION
Improved precision can only result from rigid control of methodology and the use of optimal reaction conditions. In addition, however, instrumentation performance must also be controlled. The possible effect of instrumentation on enzyme values is illustrated in a study by Maclin and colleagues Quality control of enzYI1re determinations (1973), who examined the potential effect of instrument temperature, volumetric, timing, and photometric errors on enzyme assay. They showed that even if an instrument was performing each individual function according to acceptable tolerance limits, if these limits were to operate in a single direction, the overall summation effect might result in variation from +35% to -41 % in observed enzyme activity.
The widespread use of spectrophotometric reaction rate methods has prompted the preparation by the American Association for Clinical Chemistry of comprehensive enzyme instrumentation specification guidelines (Tietz, 1977) , the adoption of which should help to solve many of the problems of instrument control.
METHOD STANDARDISATION
Though procedural control ensures precision, accuracy can be assessed only by comparison, generally with laboratories using similar methodology. The advantages of enzyme method standardisation are:
(1) They permit result comparison.
(2) They permit the development of reference laboratories.
(3) Assigned values can be designated for reference materials. (4) The performance of control materials can be evaluated. (5) Normal ranges can be established. (6) Patient data can be evaluated in terms of the effect of disease on enzyme values compared to normal. The effect of method standardisation on accuracy is illustrated by the data of the Scandinavian Society for Clinical Chemistry and Clinical Physiology (Stromme et al., 1976) . For the four enzymes, alanine transaminase, aspartate transaminase, lactate dehydrogenase, and alkaline phosphatase, considered together, interlaboratory precision (which provides a measure of accuracy) showed a coefficient of variation of 25 % with conventional methods, which improved to 10·6% with standardised methods. Similarly, whereas 52 %of results were outside 10% of the target value with conventional methods, this was reduced to 22 % with standardised methods.
REFERENCE MATERIALS
Complementary to the development of standardised methodology is the use of suitable enzyme reference materials. These materials can serve: (1) as an activity source for reference methods; (2) to establish the bias of other methods; (3) for routine quality control both for precision control and, with assigned 75 values by standard methods, for accuracy control; and (4) for calibration of secondary enzyme methods.
The constraints of instrumentation, particularly the use of multichannel analysers, may debar a laboratory from using a recommended standard procedure or so-called primary method in which enzyme activity is calculated from an observed absorbance change and the molar absorbance or extinction coefficient of an enzyme product. Instead, sample enzyme activity is established by comparison with a second enzyme material or calibrator used for instrumental setting.
It is important to recognise that the requirements for a calibrator differ from those of a control. Specifications for both have been proposed by Fasce and colleagues (1973) . A calibrator should: (1) be rather insensitive to minor analytical variation;
(2) be free from interferences; (3) have high activity for multipoint calibration or linearity checking; and (4) behave in a manner similar to human material, a property known as 'commutability', though it need not be in a human serum matrix.
A control material: (1) should permit the detection of problems in an analytical procedure, before these affect patient samples, and should therefore be more sensitive to analytic variation than such samples; (2) may, therefore, have added interferences; (3) should be free from indicator enzyme; and (4) should have a matrix resembling human serum to avoid discrepancies due to viscosity differences.
Though special-purpose calibrator and control material is ideal, purified enzyme material reconstituted in a protein matrix can serve as a compromise all-purpose material. Currently, I would advise that where an instrument is calibrated with commercial material from one source, sera from a second source should be used for control.
One primary requirement for all reference materials is adequate stability. Available commercial controls appear to have acceptable storage stability. Lawson and colleagues (1977) studied several lots of lyophilised sera from five different manufacturers. Instability was defined as deviation from zero of the regression line of activity versus time with 95 % probability. For aspartate transaminase, alkaline phosphatase, and lactate dehydrogenase, instability was generally below 5 % per year. Creatine kinase activity, however, changed by some 18% with a year's storage. However, storage stability has been considered as adequate if monthly instability is less than half average monthly between-day analytic variation. For all these enzymes this is the case, and, using this criterion, creatine kinase would be considered as adequately stable for some fOUT months.
A problem with lyophilised controls is variable stability after reconstitution. This necessitates rigid guidelines for their use if assigned values are to be attached. The increase in alkaline phosphatase in many reconstituted control sera on storage is a familiar example.
A recent development in enzyme quality control is the availability of commercial liquid controls preserved with glycerol and stored at subzero temperatures.
External control-proficiency surveys
Apart from internal control, most laboratories participate in proficiency surveys. Enyzme material is circulated, and the accuracy of each laboratory is assessed in relation to a mean or target value. Method differences between laboratories complicate the interpretation of such surveys, but two techniques have been used for circumventing this. The first is the use of so-called dimensionless data which express activity values obtained on one reference material as a ratio or percentage of that obtained on a second (Rosalki, 1972) . The second technique uses some form of conversion of one method to another. Because of the variety of enzyme methods used, it is generally impossible for survey organisers to have conversion factors available to permit such comparisons, but such factors can be generated by laboratories by the provision of a number of control materials with linearity-related activity, as suggested by Grannis (1976; . Such material should yield linearly related results, and, in the absence of interferences, the slope of all methods should cut the X axis at the same point. The technique can demonstrate interference, nonlinearity and imprecision, and bias as shown by a slope differing from that of a reference method. It can permit the generation of method conversion factors which can be used to assess accuracy in consecutive trials. Such conversion factors can be valid, however, only if the reference material is of defined composition and is constant from survey to survey. It is not considered acceptable to use conversion factors on uncharacterised human material (Rosalki et al., 1976) . I: • It must be recognised that enzyme methodology is currently changing, and methods for the measurement of enzymes by their mass concentration, especially by radioimmunoassay (RIA), are under development. Mass concentration measurement of enzymes does not solve all problems of enzyme quality control; it substitutes others. For example, variation in quoted normal ranges for CK-MB by RIA (Neumeier et al., 1977; Roberts et al., 1977;  Rosalki Willerson et al., 1977) could be a consequence of variation in the purity of the enzyme antigen. It must be emphasised that RIA methods will have impact only when they substitute for activity measurements in the routine laboratory.
